BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25769577)

  • 41. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.
    Hong SI; Ahn S; Lee YS; Kim WY; Lim KS; Lee JH; Lee JL
    Support Care Cancer; 2016 Mar; 24(3):1011-7. PubMed ID: 26238629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Spatz C; Saadulla L; Lapsiwala A; Parhizgar A; Ghahramani N
    Iran J Kidney Dis; 2012 Nov; 6(6):432-6. PubMed ID: 23146980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Rosenstock JL; Gilles E; Geller AB; Panagopoulos G; Mathew S; Malieckal D; DeVita MV; Michelis MF
    Int Urol Nephrol; 2010 Dec; 42(4):1049-54. PubMed ID: 20602168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iodinated contrast agent-induced nephropathy].
    Erley C
    Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can sodium fluorescein cause contrast-induced nephropathy?
    Yun D; Kim DK; Lee JP; Kim YS; Oh S; Lim CS
    Nephrol Dial Transplant; 2021 Apr; 36(5):819-825. PubMed ID: 31773157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
    Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
    Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
    McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study.
    Kim MH; Koh SO; Kim EJ; Cho JS; Na SW
    BMC Anesthesiol; 2015; 15():23. PubMed ID: 25780349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke.
    Sharma J; Nanda A; Jung RS; Mehta S; Pooria J; Hsu DP
    J Neurointerv Surg; 2013 Nov; 5(6):543-5. PubMed ID: 23125428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
    Lakhal K; Ehrmann S; Chaari A; Laissy JP; RĂ©gnier B; Wolff M; Pajot O
    J Crit Care; 2011 Dec; 26(6):593-9. PubMed ID: 21737245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
    Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
    Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.